All filters
E-Posters
Multicentric Castleman Disease HHV-8 Related In A HIV Patient
A. Gjataj
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Variability In HIV Proviral DNA Genotyping Results From A Single Blood Draw
R. Acosta
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Virological Efficacy And Resistance Evaluation In People Living With HIV Starting An STR Regimen
G. Stella
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Molecular Characterization In Hcv Late Relapser Patients Treated With Direct-Acting Antiviral (DAA) Drugs
M. Rueca
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Pharmaco-Virological Algorithm To Target Risk Of Resistance Among A Population Of HIV-Infected Female Sex Workers In Togo
C. Charpentier
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Impact Of Sexually Transmitted Infections On Seminal HIV Levels Among Undetectable Patients
R. Scutari
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Bone Mineral Density In Patients With HIV Infection And Chronic Hepatitis C
A. Timchev
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Seroprevalence And Co-Infections HIV, HBV And HCV Among Clinic Attenders At Laquintinie Hospital In Douala, Cameroon
P. D. Djouela Djoulako
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Long-Acting Cabotegravir + Rilpivirine for HIV Treatment: FLAIR Week 96 Results
R. D'Amico Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Optimisation of First-Line Antiretroviral Therapy (ART) for Children Living with HIV in Uganda: Translation from policy to action
E. Magongo Reviews in Antiviral Therapy & Infectious Diseases 7, 2020  
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Dual therapy including dolutegravir plus boosted-darunavir ensures high rate of virological control and rare resistance selection at failure in heavily treatment experienced PLWH
D. Armenia Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Dual therapy with Dolutegravir plus Lamivudine in virologically suppressed patients
C. Valente Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Real-world effectiveness of elbasvir/grazoprevir in the treatment of patients with hepatitis C virus genotype 1a infection in Norway
R. Leiva Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
HIV A1 or B Do Not Differentially Impact Cabotegravir In Vitro Potency or Durability
J. Jeffrey Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
HIV evolution in patients initiating antiretroviral therapy during primary infection
B. Abdi Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020